Catalent
CTLT
#1585
Rank
ยฃ8.29 B
Marketcap
ยฃ45.72
Share price
-0.18%
Change (1 day)
16.57%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Earnings for Catalent (CTLT)

Earnings in 2024 (TTM): -ยฃ0.64 B

According to Catalent's latest financial reports the company's current earnings (TTM) are -ยฃ0.59 B. In 2023 the company made an earning of -ยฃ0.92 B a decrease over its 2022 earnings that were of ยฃ0.49 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalent from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ0.64 B-31.26%
2023 -ยฃ0.92 B-286.27%
2022 ยฃ0.49 B-25.81%
2021 ยฃ0.66 B77.66%
2020 ยฃ0.37 B62.46%
2019 ยฃ0.23 B10.64%
2018 ยฃ0.20 B18.66%
2017 ยฃ0.17 B9.14%
2016 ยฃ0.16 B-15.11%
2015 ยฃ0.18 B15.35%
2014 ยฃ0.16 B10.45%
2013 ยฃ0.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ28.51 M-104.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ17.71 M-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.22 B-138.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-ยฃ44.21 M-92.50%๐Ÿ‡บ๐Ÿ‡ธ USA